AcelRx Pharmaceuticals

AcelRx Pharmaceuticals Receives U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms

The two new patents cover the company's family of sufentanil NanoTab pain products.

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S.

No votes yet
Syndicate content